Clinical Trial Update: Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study evaluating SP2086 in combination with metformin for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED